-
Mashup Score: 33
Alan Skarbnik, MD, and Manni Mohyuddin, MBBS, discuss the concept of MRD in hematologic malignancies.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 33
Alan Skarbnik, MD, and Manni Mohyuddin, MBBS, discuss the concept of MRD in hematologic malignancies.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 12Papa Heme Talks Castleman Disease Next #HemOncPulse With #ChadiNabhan @bloodcancerstoday2935 - 1 month(s) ago
Aaron Goodman, MD, of the University of California, San Diego Health gives a 360-degree view on Castleman disease on the next episode of The HemOnc Pulse on …
Source: www.youtube.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2Hematology and Oncology Fellow Education About Sexual and Reproductive Health: A Survey of Program Directors in the United States - 3 month(s) ago
PURPOSE Clinical oncology guidelines recommend addressing sexual and reproductive health (SRH) concerns in routine cancer care. However, limited training often hinders clinicians’ ability to do so effectively. The objective of this study was to understand the state of current fellowship education on SRH (ie, sexual health, safe sex practices, and fertility) through conducting a national survey of US hematology/oncology fellowship program directors (PDs). METHODS A survey was sent to all PDs of adult hematology/oncology fellowship programs in the United States via online link. PDs who did not complete the survey were sent up to four follow-up emails and a paper mailing. Descriptive statistics and McNemar tests were conducted. RESULTS One hundred-fourteen PDs responded (65%). Fewer programs offered formal instruction on sexual health (49%) and safe sex practices (37%) compared with fertility (75%). Informal training in SRH relied heavily on direct clinical experience (73%-78% of programs
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4The HemOnc Pulse: Drs. Dahiya, Spiegel Discuss CAR-T Secondary Malignancies Risk on Apple Podcasts - 3 month(s) ago
Show The HemOnc Pulse, Ep Drs. Dahiya, Spiegel Discuss CAR-T Secondary Malignancies Risk – Feb 8, 2024
Source: podcasts.apple.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 9Clinician-Researcher by Day … Podcaster/Social Media Guru by Night? | Blood Cancers Today - 3 month(s) ago
Hematologist-oncologists are increasingly turning to podcasts and social media to learn about new data and to share research.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 11
Susan Parsons, MD, MRP; Andrew Evans, DO, MBA, MSc; and Matthew Maurer, DMSc; discuss the HoLISTIC consortium.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 5FDA grants accelerated approval to pirtobrutinib - 5 month(s) ago
On December 1, 2023, the Food and Drug Administration granted accelerated approval to pirtobrutinib (Jaypirca, Eli Lilly and Company) for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who have received at least two prior lines of therapy, including a BTK inhibitor.
Source: www.fda.govCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 4Digital Equity in Hematology-Oncology Fellowship Websites: Toward Standardization, Quality, and Transparency - 6 month(s) ago
Improving trainee program websites may help applicants and programs in the era of virtual interviews
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Digital Equity in Hematology-Oncology Fellowship Websites: Toward Standardization, Quality, and Transparency - 6 month(s) ago
Improving trainee program websites may help applicants and programs in the era of virtual interviews
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
My latest #HemOnc Pulse is out W @ManniMD1 & @ASkarbnik discussing the "concept of MRD" in Heme malignancies. Impact of MRD likely varies based on the Dx & goals of Tx, but it is critical to address. Listen to the entire discussion here @Blood_Cancers https://t.co/S93jVt0nqp